Clinical trial Recruiting at 1 site Interventional Ages 20 to 70

Using Transcranial Magnetic Stimulation to Treat Neuropathic Pain in Spinal Cord Injury Patients

Official title: Effect of Repetative Transcranial Magnetic Stimulation Therapy on Neuropathic Pain in Patients With Spinal Cord Injury

Run by Afyonkarahisar Health Sciences University · NCT05645003 · Data updated 2026-11-12

This study is testing whether a type of brain stimulation called rTMS can help reduce neuropathic pain in people with spinal cord injuries.

More Neuropathic Pain trials

Quick facts

Study typeInterventional
Ages20 Years to 70 Years
SexAll
Enrollment60 (estimated)
SponsorAfyonkarahisar Health Sciences University
Academic / other
Locations1 site (Afyonkarahisar)
StatusRecruiting
StartedNovember 15, 2022
Main results expectedMarch 31, 2026
Study endsMarch 31, 2026
Registry record updatedMarch 9, 2026
Trial IDNCT05645003 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 20-70 with spinal cord injuries and neuropathic pain lasting at least six months.

Probably not a fit

Patients with severe comorbid conditions, cognitive dysfunction, or contraindications to rTMS will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effects of high-frequency Repetitive Transcranial Magnetic Stimulation (rTMS) therapy on neuropathic pain in patients with spinal cord injuries. The therapy targets the dorsolateral prefrontal cortex (DLPFC), an area that has been less studied compared to the primary motor cortex. Participants will receive either active rTMS or a sham treatment to assess the efficacy of this non-invasive brain stimulation technique in alleviating pain. The study aims to provide insights into the potential benefits of rTMS as an adjunct to existing pain management strategies for spinal cord injury patients.

Why it matters

Potential benefit: If successful, this treatment could significantly reduce neuropathic pain and improve the quality of life for patients with spinal cord injuries.

How similar studies have gone: While studies on rTMS targeting the primary motor cortex have shown promise, the specific application to the DLPFC in this context is less explored, making this approach somewhat novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Between the ages of 20-70, who applied to the AFSU Physical Medicine and Rehabilitation inpatient service with the diagnosis of spinal cord injury and

* Having spinal cord injury with neurophatic pain at least six months ago,
* Able to follow two-stage verbal commands,
* Agreeing to participate in the study voluntarily and regularly,
* Patients who are medically stable (no previous myocardial infarction, no musculoskeletal problems) will be included in our study.

Exclusion Criteria:

Having an important comorbid disease such as severe heart disease (aortic stenosis, angina, hypertrophic cardiomyopathy, arrhythmia, pacemaker) and uncontrolled hypertension,

* Epilepsy,
* History of antiepileptic drug use,
* Intracranial metal object,
* Presence of in-ear implant,
* Cognitive dysfunction,
* Lower extremity peripheral nerve injury,
* With malignancy and active infection,
* Infection on the skin in the application area,
* Having an open wound,
* Having inflammatory disease,
* Orthopedic injuries that can limit maximum effort contractions,
* Having a brain lesion or a history of drug use that will affect the seizure threshold,
* Patients with increased intracranial pressure or uncontrolled migraine will not be included.

Where it's running

  • Afyonkarahisar
    Afyonkarahisar, Turkey (Türkiye)
    Recruiting

Study contacts

  • Principal investigator: Nuran EYVAZ, MD — Afyonkarahisar Health Sciences University
  • Study coordinator: Nuran EYVAZ, MD
  • Email: n_eyvaz@hotmail.com
  • Phone: +905334262442

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.